デフォルト表紙
市場調査レポート
商品コード
1698084

海洋由来医薬品市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、供給源別、用途別、地域別、競合別セグメント、2020-2030年

Marine Derived Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Source, By Application, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
海洋由来医薬品市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、供給源別、用途別、地域別、競合別セグメント、2020-2030年
出版日: 2025年03月28日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

海洋由来医薬品の世界市場規模は2024年に124億米ドルとなり、2030年までのCAGRは9.10%と、予測期間中に目覚ましい成長を遂げると予測されています。

世界の海洋由来医薬品市場は、藻類、海綿動物、サンゴ、海洋微生物を含む海洋生物由来の生物活性化合物を活用し、革新的な治療薬を開発する製薬業界の専門分野です。これらの化合物はユニークな薬理学的特性を持ち、複雑な病態をターゲットとする次世代医薬品の創出を可能にします。

市場概要
予測期間 2026-2030
市場規模：2024年 124億米ドル
市場規模：2030年 209億6,000万米ドル
CAGR：2025年～2030年 9.10%
急成長セグメント ペプチド
最大市場 北米

海洋バイオテクノロジー、特に海洋ゲノミクスとバイオインフォマティクスの進歩により、新規医薬品の同定が加速しています。これらのブレークスルーは、抗菌剤耐性や従来の合成医薬品に関連する副作用といった業界の重要な課題に対処するものです。さらに、市場は持続可能な海洋生物探索への戦略的シフトを目の当たりにしており、藻類由来化合物はその拡張性と世界の持続可能性イニシアティブとの整合性から、支配的なセグメントとして台頭してきています。

市場促進要因

海洋生態系の豊かな生物多様性

主な市場課題

発見・開発コストの高さ

主要市場動向

ゲノムおよびメタゲノム技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の海洋由来医薬品市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別（エーテル、ペプチド、フェノール、ステロイド）
    • 発生源別（藻類、無脊椎動物、微生物）
    • 用途別（抗心血管、抗炎症、抗菌、抗腫瘍、抗ウイルス）
    • 地域別
    • 企業別（2024）
  • 製品市場マップ
    • タイプ別
    • ソース別
    • 用途別
    • 地域別

第6章 北米の海洋由来医薬品市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の海洋由来医薬品市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の海洋由来医薬品市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米の海洋由来医薬品市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの海洋由来医薬品市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Abbott Laboratories Inc
  • Bayer AG
  • Takeda Pharmaceutical Co Ltd
  • Marine Polymer Technologies Inc
  • Sanofi SA
  • Aphios Corp
  • Aker BioMarine ASA
  • AbbVie Inc
  • GSK PLCC

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 17557

Global Marine Derived Drugs Market was valued at USD 12.40 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.10% through 2030. The global marine-derived drugs market is a specialized segment of the pharmaceutical industry that leverages bioactive compounds from marine organisms-including algae, sponges, corals, and marine microorganisms-to develop innovative therapeutics. These compounds offer unique pharmacological properties, enabling the creation of next-generation drugs targeting complex medical conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 12.40 Billion
Market Size 2030USD 20.96 Billion
CAGR 2025-20309.10%
Fastest Growing SegmentPeptide
Largest MarketNorth America

Advancements in marine biotechnology, particularly in marine genomics and bioinformatics, are accelerating the identification of novel pharmaceutical agents. These breakthroughs address critical industry challenges such as antimicrobial resistance and adverse effects linked to conventional synthetic drugs. Furthermore, the market is witnessing a strategic shift toward sustainable marine bioprospecting, with algae-derived compounds emerging as a dominant segment due to their scalability and alignment with global sustainability initiatives.

Key Market Drivers

Rich Biodiversity of Marine Ecosystems

The vast and diverse ecosystems of the world's oceans serve as an untapped reservoir of bioactive compounds with immense pharmaceutical potential. The rich biodiversity of marine environments is a key driver behind the expansion of the global marine-derived drugs market, fueling novel drug discovery and commercialization.

Marine ecosystems, spanning more than 70% of the Earth's surface, serve as a vast reservoir of biologically active compounds. These environments host a diverse array of microorganisms, invertebrates, and marine plants, many of which produce structurally unique secondary metabolites. These bioactive compounds are increasingly recognized for their potential in pharmaceutical innovation, offering novel therapeutic mechanisms that differentiate them from traditional synthetic drugs. These bioactive compounds, evolved over millions of years, exhibit structural complexity and pharmacological properties that are rarely found in terrestrial organisms. Marine-derived molecules such as peptides, alkaloids, polyketides, and terpenoids have demonstrated anti-cancer, anti-inflammatory, antimicrobial, and neuroprotective activities. Unlike terrestrial organisms, marine species thrive in extreme conditions (deep-sea trenches, hydrothermal vents, Arctic waters), leading to the evolution of highly potent and stable bioactive compounds that can withstand diverse physiological environments in drug formulations. This unparalleled chemical diversity positions marine ecosystems as high-value resources for next-generation pharmaceuticals targeting diseases with limited treatment options.

Key Market Challenges

High Cost of Discovery and Development and

One of the most significant challenges in the marine-derived drugs market is the high cost associated with the discovery and development of new drugs. The process of identifying, isolating, and testing marine compounds is time-consuming and resource intensive. Researchers often require specialized equipment and access to remote marine environments, which adds to the overall expense.

Key Market Trends

Advancements in Genomic and Metagenomic Technologies

Genomic and metagenomic technologies are revolutionizing marine drug discovery. By analyzing the DNA of marine organisms and their symbiotic microorganisms, researchers can identify potential drug candidates more efficiently. These techniques enable the discovery of previously hidden bioactive compounds and hold the promise of accelerating drug development.

Key Market Players

  • Abbott Laboratories Inc
  • Bayer AG
  • Takeda Pharmaceutical Co Ltd
  • Marine Polymer Technologies Inc
  • Sanofi SA
  • Aphios Corp
  • Aker BioMarine ASA
  • AbbVie Inc
  • GSK PLC

Report Scope:

In this report, the Global Marine Derived Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Marine Derived Drugs Market, By Type:

  • Ether
  • Peptide
  • Phenol
  • Steroid

Marine Derived Drugs Market, By Source:

  • Algae
  • Invertebrates
  • Microorganisms

Marine Derived Drugs Market, By Application:

  • Anti-Cardiovascular
  • Anti-Inflammatory
  • Anti-Microbial
  • Anti-Tumor
  • Anti-Viral

Marine Derived Drugs Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Marine Derived Drugs Market.

Available Customizations:

Global Marine Derived Drugs market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Marine Derived Drugs Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Ether, Peptide, Phenol, Steroid)
    • 5.2.2. By Source (Algae, Invertebrates, Microorganisms)
    • 5.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Type
    • 5.3.2. By Source
    • 5.3.3. By Application
    • 5.3.4. By Region

6. North America Marine Derived Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Ether, Peptide, Phenol, Steroid)
    • 6.2.2. By Source (Algae, Invertebrates, Microorganisms)
    • 6.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Marine Derived Drugs Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Source
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Marine Derived Drugs Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Source
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Marine Derived Drugs Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Source
        • 6.3.3.2.3. By Application

7. Europe Marine Derived Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Ether, Peptide, Phenol, Steroid)
    • 7.2.2. By Source (Algae, Invertebrates, Microorganisms)
    • 7.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Marine Derived Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Application
    • 7.3.2. United Kingdom Marine Derived Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Application
    • 7.3.3. France Marine Derived Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Marine Derived Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Source
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Marine Derived Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Source
        • 7.3.5.2.3. By Application

8. Asia-Pacific Marine Derived Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Ether, Peptide, Phenol, Steroid)
    • 8.2.2. By Source (Algae, Invertebrates, Microorganisms)
    • 8.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Marine Derived Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Application
    • 8.3.2. Japan Marine Derived Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Application
    • 8.3.3. India Marine Derived Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Application
    • 8.3.4. Australia Marine Derived Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Application
    • 8.3.5. South Korea Marine Derived Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Application

9. South America Marine Derived Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Ether, Peptide, Phenol, Steroid)
    • 9.2.2. By Source (Algae, Invertebrates, Microorganisms)
    • 9.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Marine Derived Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Marine Derived Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Marine Derived Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Application

10. Middle East and Africa Marine Derived Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Ether, Peptide, Phenol, Steroid)
    • 10.2.2. By Source (Algae, Invertebrates, Microorganisms)
    • 10.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Marine Derived Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Marine Derived Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Marine Derived Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Application
    • 10.3.4. Kuwait Marine Derived Drugs Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Source
        • 10.3.4.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Abbott Laboratories Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Bayer AG
  • 14.3. Takeda Pharmaceutical Co Ltd
  • 14.4. Marine Polymer Technologies Inc
  • 14.5. Sanofi SA
  • 14.6. Aphios Corp
  • 14.7. Aker BioMarine ASA
  • 14.8. AbbVie Inc
  • 14.9. GSK PLCC

15. Strategic Recommendations

16. About Us & Disclaimer